RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Dipak Banerjee to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Dipak Banerjee has written about Dose-Response Relationship, Drug.
Dipak Banerjee
Connection Strength
0.183
Dose-Response Relationship, Drug
  1. Banerjee A, Martinez JA, Longas MO, Zhang Z, Santiago J, Baksi K, Banerjee DK. N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic. Adv Exp Med Biol. 2015; 842:355-74.
    View in: PubMed
    Score: 0.100
  2. Banerjee DK, Carrasquillo EA, Hughey P, Schutzbach JS, Mart?nez JA, Baksi K. In vitro phosphorylation by cAMP-dependent protein kinase up-regulates recombinant Saccharomyces cerevisiae mannosylphosphodolichol synthase. J Biol Chem. 2005 Feb 11; 280(6):4174-81.
    View in: PubMed
    Score: 0.050
  3. Mart?nez JA, Torres-Negr?n I, Amig? LA, Banerjee DK. Expression of Glc3Man9GlcNAc2-PP-Dol is a prerequisite for capillary endothelial cell proliferation. Cell Mol Biol (Noisy-le-grand). 1999 Feb; 45(1):137-52.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support